FDA warning letter · Drugs

Lupin Limited

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

Failure to establish adequate written procedures for cleaning equipment and its release for use in manufacture of intermediates and API.

Passage 2

Failure to establish written procedures to monitor the progress and control the performance of processing steps that may cause variability in the quality characteristics of your intermediates and API.

Passage 3

Failure to investigate all critical deviations.